vimarsana.com
Home
Live Updates
PADA-1 Trial: ctDNA Monitoring for Acquired ESR1 Mutations in Advanced Breast Cancer : vimarsana.com
PADA-1 Trial: ctDNA Monitoring for Acquired ESR1 Mutations in Advanced Breast Cancer
Drs Mayer and Kalinsky provide insights and offer their impressions of the PADA-1 trial, focusing on ESR1 mutation monitoring with circulating tumor DNA (ctDNA).
Related Keywords
,
Breast Cancer ,
Advanced Breast ,
Hr Breast Cancer ,
Hr Positive Breast Cancer ,
Breast Cancer Treatment ,
Esr1 ,
Esr1 Mutations ,
Biomarker Testing ,
Esr1 Testing ,
Pada 1 ,
Ctdna ,
Circulating Tumor Dna ,
Aromatase Inhibitor ,
Fulvestrant ,
Patient Monitoring ,
vimarsana.com © 2020. All Rights Reserved.